Does DIFFU K Cause Pulmonary arterial hypertension? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Pulmonary arterial hypertension have been filed in association with DIFFU K. This represents 21.7% of all adverse event reports for DIFFU K.
5
Reports of Pulmonary arterial hypertension with DIFFU K
21.7%
of all DIFFU K reports
0
Deaths
3
Hospitalizations
How Dangerous Is Pulmonary arterial hypertension From DIFFU K?
Of the 5 reports, 3 (60.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.
Is Pulmonary arterial hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIFFU K. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DIFFU K Cause?
What Other Drugs Cause Pulmonary arterial hypertension?
TREPROSTINIL (3,240)
MACITENTAN (2,390)
AMBRISENTAN (1,965)
SELEXIPAG (1,387)
EPOPROSTENOL (1,055)
BOSENTAN (778)
TADALAFIL (680)
SILDENAFIL (487)
RIOCIGUAT (436)
ILOPROST (284)